A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24%
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 9/15/2017 |
| Start Date: | June 2014 |
| End Date: | August 2014 |
The purpose of this study is to evaluate the Plasma Pharmacokinetics and Safety of AC 170
0.24% in Healthy, Adult Subjects when used twice daily for one week.
0.24% in Healthy, Adult Subjects when used twice daily for one week.
Inclusion Criteria:
- at least 18 and no older than 55 years of age
- be able to self-administer eye drops or have a parent/legal guardian available for
this purpose
- have blood and urine analysis within normal limits
- have ocular health within normal limits
Exclusion Criteria:
- known contraindications or sensitivities to the study medication or its components
- have any active systemic or ocular disorder (other than refractive disorder)
- have inability to comply with controlled diet
- have used prescription or non prescription drugs within washout period and throughout
study
- have used alcohol or tobacco within the washout period
We found this trial at
1
site
Click here to add this to my saved trials
